United States· US:66993-371_b5744adc-ae2c-4b1b-adaa-3e4fa2a287f9
medroxyprogesterone acetate
A medicinal product containing medroxyprogesterone acetate, registered in United States by Prasco Laboratories.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MEDROXYPROGESTERONE ACETATE
- Manufacturer
- Prasco Laboratories
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 2
- ndc1166993371791 SYRINGE in 1 CARTON (66993-371-79) / 1 mL in 1 SYRINGE
- ndc1166993-371-79
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Medroxyprogesterone acetate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandDepo-Provera 150 mg/ml Suspension for InjectionPfizer Healthcare Ireland Unlimited Company
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
- United KingdomAdgyn Medro 5mg tabletsKyowa Kirin Ltd
- FinlandCykrinaWyeth Medica Ireland
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CzechiaDEPO-PROVERAPfizer, spol. s r.o., Praha
- CanadaAA-MEDROXYAA PHARMA INC
- Japanメドロキシプロゲステロン酢酸エステル東和薬品
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8776289-f4dc-4bdd-a610-0dc051ddc2cc GET /v1/drugs/b8776289-f4dc-4bdd-a610-0dc051ddc2cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": "150",
"substance": "MEDROXYPROGESTERONE ACETATE",
"productndc": "66993-371",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA020246",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about medroxyprogesterone acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.